High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men


Elucidating virus-host interactions responsible for HIV-1 transmission is important for advancing HIV-1 prevention strategies. To this end, single genome amplification (SGA) and sequencing of HIV-1 within the context of a model of random virus evolution has made possible for the first time an unambiguous identification of transmitted/founder viruses and a precise estimation of their numbers. Here, we applied this approach to HIV-1 env analyses in a cohort of acutely infected men who have sex with men (MSM) and found that a high proportion (10 of 28; 36%) had been productively infected by more than one virus. In subjects with multivariant transmission, the minimum number of transmitted viruses ranged from 2 to 10 with viral recombination leading to rapid and extensive genetic shuffling among virus lineages. A combined analysis of these results, together with recently published findings based on identical SGA methods in largely heterosexual (HSX) cohorts, revealed a significantly higher frequency of multivariant transmission in MSM than in HSX [19 of 50 subjects (38%) versus 34 of 175 subjects (19%); Fisher's exact p = 0.008]. To further evaluate the SGA strategy for identifying transmitted/founder viruses, we analyzed 239 overlapping 5′ and 3′ half genome or env-only sequences from plasma viral RNA (vRNA) and blood mononuclear cell DNA in an MSM subject who had a particularly well-documented virus exposure history 3–6 days before symptom onset and 14–17 days before peak plasma viremia (47,600,000 vRNA molecules/ml). All 239 sequences coalesced to a single transmitted/founder virus genome in a time frame consistent with the clinical history, and a molecular clone of this genome encoded replication competent virus in accord with model predictions. Higher multiplicity of HIV-1 infection in MSM compared with HSX is consistent with the demonstrably higher epidemiological risk of virus acquisition in MSM and could indicate a greater challenge for HIV-1 vaccines than previously recognized.


Vyšlo v časopise: High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. PLoS Pathog 6(5): e32767. doi:10.1371/journal.ppat.1000890
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000890

Souhrn

Elucidating virus-host interactions responsible for HIV-1 transmission is important for advancing HIV-1 prevention strategies. To this end, single genome amplification (SGA) and sequencing of HIV-1 within the context of a model of random virus evolution has made possible for the first time an unambiguous identification of transmitted/founder viruses and a precise estimation of their numbers. Here, we applied this approach to HIV-1 env analyses in a cohort of acutely infected men who have sex with men (MSM) and found that a high proportion (10 of 28; 36%) had been productively infected by more than one virus. In subjects with multivariant transmission, the minimum number of transmitted viruses ranged from 2 to 10 with viral recombination leading to rapid and extensive genetic shuffling among virus lineages. A combined analysis of these results, together with recently published findings based on identical SGA methods in largely heterosexual (HSX) cohorts, revealed a significantly higher frequency of multivariant transmission in MSM than in HSX [19 of 50 subjects (38%) versus 34 of 175 subjects (19%); Fisher's exact p = 0.008]. To further evaluate the SGA strategy for identifying transmitted/founder viruses, we analyzed 239 overlapping 5′ and 3′ half genome or env-only sequences from plasma viral RNA (vRNA) and blood mononuclear cell DNA in an MSM subject who had a particularly well-documented virus exposure history 3–6 days before symptom onset and 14–17 days before peak plasma viremia (47,600,000 vRNA molecules/ml). All 239 sequences coalesced to a single transmitted/founder virus genome in a time frame consistent with the clinical history, and a molecular clone of this genome encoded replication competent virus in accord with model predictions. Higher multiplicity of HIV-1 infection in MSM compared with HSX is consistent with the demonstrably higher epidemiological risk of virus acquisition in MSM and could indicate a greater challenge for HIV-1 vaccines than previously recognized.


Zdroje

1. HaaseAT

2005 Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 5 783 792

2. HladikF

McElrathMJ

2008 Setting the stage: host invasion by HIV. Nat Rev Immunol 8 447 457

3. PopeM

HaaseAT

2003 Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat Med 9 847 852

4. ShattockRJ

MooreJP

2003 Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 1 25 34

5. Rerks-NgarmS

PitisuttithumP

NitayaphanS

KaewkungwalJ

ChiuJ

2009 Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 361 2209 2220

6. DolinR

2009 HIV vaccine trial results–an opening for further research. N Engl J Med 361 2279 2280

7. LetvinNL

2009 Moving forward in HIV vaccine development. Science 326 1196 1198

8. AbrahamsMR

AndersonJA

GiorgiEE

SeoigheC

MlisanaK

2009 Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol 83 3556 3567

9. HaalandRE

HawkinsPA

Salazar-GonzalezJ

JohnsonA

TichacekA

2009 Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 5 e1000274

10. KeeleBF

GiorgiEE

Salazar-GonzalezJF

DeckerJM

PhamKT

2008 Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105 7552 7557

11. Salazar-GonzalezJF

BailesE

PhamKT

SalazarMG

GuffeyMB

2008 Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 82 3952 3970

12. Salazar-GonzalezJF

SalazarMG

KeeleBF

LearnGH

GiorgiEE

2009 Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206 1273 1289

13. KeeleBF

LiH

LearnGH

HraberP

GiorgiEE

2009 Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med 206 1117 1134

14. DerdeynCA

DeckerJM

Bibollet-RucheF

MokiliJL

MuldoonM

2004 Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303 2019 2022

15. GottliebGS

HeathL

NickleDC

WongKG

LeachSE

2008 HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis 197 1011 1015

16. GroblerJ

GrayCM

RademeyerC

SeoigheC

RamjeeG

2004 Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J Infect Dis 190 1355 1359

17. LearnGH

MuthuiD

BrodieSJ

ZhuT

DiemK

2002 Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol 76 11953 11959

18. LongEM

MartinHLJr

KreissJK

RainwaterSM

LavreysL

2000 Gender differences in HIV-1 diversity at time of infection. Nat Med 6 71 75

19. PossM

MartinHL

KreissJK

GranvilleL

ChohanB

1995 Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J Virol 69 8118 8122

20. RitolaK

PilcherCD

FiscusSA

HoffmanNG

NelsonJA

2004 Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J Virol 78 11208 11218

21. SagarM

KirkegaardE

LongEM

CelumC

BuchbinderS

2004 Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol 78 7279 7283

22. WolfsTF

ZwartG

BakkerM

GoudsmitJ

1992 HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189 103 110

23. WolinskySM

WikeCM

KorberBT

HuttoC

ParksWP

1992 Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants. Science 255 1134 1137

24. ZhuT

MoH

WangN

NamDS

CaoY

1993 Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 1179 1181

25. MargolisL

ShattockR

2006 Selective transmission of CCR5-utilizing HIV-1: the ‘gatekeeper’ problem resolved? Nat Rev Microbiol 4 312 317

26. MooreJP

KitchenSG

PugachP

ZackJA

2004 The CCR5 and CXCR4 coreceptors–central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 20 111 126

27. RichmanDD

BozzetteSA

1994 The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 169 968 974

28. LiQ

DuanL

EstesJD

MaZM

RourkeT

2005 Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434 1148 1152

29. LiQ

EstesJD

SchlievertPM

DuanL

BrosnahanAJ

2009 Glycerol monolaurate prevents mucosal SIV transmission. Nature 458 1034 1038

30. LiQ

SkinnerPJ

HaSJ

DuanL

MattilaTL

2009 Visualizing antigen-specific and infected cells in situ predicts outcomes in early viral infection. Science 323 1726 1729

31. MillerCJ

LiQ

AbelK

KimEY

MaZM

2005 Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus. J Virol 79 9217 9227

32. HladikF

SakchalathornP

BallweberL

LentzG

FialkowM

2007 Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 26 257 270

33. FiebigEW

WrightDJ

RawalBD

GarrettPE

SchumacherRT

2003 Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17 1871 1879

34. LeeHY

GiorgiEE

KeeleBF

GaschenB

AthreyaGS

2009 Modeling sequence evolution in acute HIV-1 infection. J Theor Biol 261 341 360

35. KearneyM

MaldarelliF

ShaoW

MargolickJB

DaarES

2009 Human immunodeficiency virus type 1 population genetics and adaptation in newly infected individuals. J Virol 83 2715 2727

36. MornerA

BjorndalA

AlbertJ

KewalramaniVN

LittmanDR

1999 Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 73 2343 2349

37. MaydtJ

LengauerT

2006 Recco: recombination analysis using cost optimization. Bioinformatics 22 1064 1071

38. HudsonRR

KaplanNL

1985 Statistical properties of the number of recombination events in the history of a sample of DNA sequences. Genetics 111 147 164

39. JungA

MaierR

VartanianJP

BocharovG

JungV

2002 Recombination: Multiply infected spleen cells in HIV patients. Nature 418 144

40. LevyDN

AldrovandiGM

KutschO

ShawGM

2004 Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A 101 4204 4209

41. ShrinerD

RodrigoAG

NickleDC

MullinsJI

2004 Pervasive genomic recombination of HIV-1 in vivo. Genetics 167 1573 1583

42. Simon-LoriereE

GalettoR

HamoudiM

ArcherJ

LefeuvreP

2009 Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog 5 e1000418

43. BimberBN

BurwitzBJ

O'ConnorS

DetmerA

GostickE

2009 Ultradeep pyrosequencing detects complex patterns of CD8+ T-lymphocyte escape in simian immunodeficiency virus-infected macaques. J Virol 83 8247 8253

44. GoonetillekeN

LiuMK

Salazar-GonzalezJF

FerrariG

GiorgiE

2009 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206 1253 1272

45. PilcherCD

FiscusSA

NguyenTQ

FoustE

WolfL

2005 Detection of acute infections during HIV testing in North Carolina. N Engl J Med 352 1873 1883

46. MehandruS

PolesMA

Tenner-RaczK

ManuelliV

Jean-PierreP

2007 Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol 81 599 612

47. VolkowP

BrouwerKC

LozaO

RamosR

LozadaR

2009 Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities. Int J Drug Policy 20 409 412

48. BarKJ

LiH

ChamberlandA

TremblayC

RoutyJP

2010 Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol xx yy zz

49. BoilyMC

Abu-RaddadL

DesaiK

MasseB

SelfS

2008 Measuring the public-health impact of candidate HIV vaccines as part of the licensing process. Lancet Infect Dis 8 200 207

50. BoilyMC

BaggaleyRF

WangL

MasseB

WhiteRG

2009 Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies. Lancet Infect Dis 9 118 129

51. PhillipsAN

1996 Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271 497 499

52. LittleSJ

McLeanAR

SpinaCA

RichmanDD

HavlirDV

1999 Viral dynamics of acute HIV-1 infection. J Exp Med 190 841 850

53. StaffordMA

CoreyL

CaoY

DaarES

HoDD

2000 Modeling plasma virus concentration during primary HIV infection. J Theor Biol 203 285 301

54. MarkowitzM

LouieM

HurleyA

SunE

Di MascioM

2003 A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J Virol 77 5037 5038

55. BuckheitRW

WatsonKM

MorrowKM

HamAS

2010 Development of topical microbicides to prevent the sexual transmission of HIV. Antiviral Res 85 142 158

56. VeazeyRS

ShattockRJ

PopeM

KirijanJC

JonesJ

2003 Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat Med 9 343 346

57. ZhuJ

HladikF

WoodwardA

KlockA

PengT

2009 Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med 15 886 892

58. Kosakovsky PondSL

PosadaD

GravenorMB

WoelkCH

FrostSD

2006 GARD: a genetic algorithm for recombination detection. Bioinformatics 22 3096 3098

59. RozasJ

Sanchez-DelBarrioJC

MesseguerX

RozasR

2003 DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19 2496 2497

60. WoodN

BhattacharyaT

KeeleBF

GiorgiE

LiuM

2009 HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLoS Pathog 5 e1000414

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa